Related Experiment Video
Updated: Oct 9, 2025

08:14
Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
18.3K
Brenner tumors.
Filipa de Sousa Costeira1, Ana Félix2, Teresa Margarida Cunha2
1Hospital de Braga, Braga, Portugal.
The British Journal of Radiology
|December 20, 2021
Summary
Brenner tumors are rare ovarian neoplasms. While typically benign and small, their imaging can mimic fibromas, requiring careful differentiation based on clinical factors and potential for malignant transformation.
Area of Science:
- Gynecologic Oncology
- Pathology
- Radiology
Background:
- Brenner tumors are uncommon ovarian neoplasms characterized by transitional cells and dense fibrous stroma.
- They are typically small (<2 cm), incidentally found in asymptomatic women.
- Predominantly fibrous composition leads to low T2-weighted signal intensity on MRI, complicating differential diagnosis.
Purpose of the Study:
- To summarize the key imaging features of Brenner tumors.
- To highlight differential diagnostic considerations with other ovarian neoplasms like fibroma and thecoma.
- To discuss the potential for malignant and borderline variants of Brenner tumors.
Main Methods:
- Review of imaging characteristics of Brenner tumors, focusing on MRI findings (T2-weighted signal).
- Comparison of imaging features with ovarian fibroma and thecoma.
- Analysis of clinical presentation and associated findings, including estrogen excess and co-existing ovarian neoplasms.
Main Results:
- Brenner tumors exhibit low signal intensity on T2-weighted MRI due to their fibrous nature.
- Differentiation from fibroma/thecoma relies on secondary signs like estrogen excess symptoms or other ovarian neoplasms (present in up to 30%).
- While predominantly benign, malignant and borderline Brenner tumors have been reported.
Conclusions:
- Brenner tumors present a diagnostic challenge due to overlapping imaging features with benign fibroblastic neoplasms.
- Clinical context, including hormonal symptoms and associated lesions, is crucial for accurate diagnosis.
- Awareness of rare malignant/borderline forms is essential for comprehensive patient management.
More Related Videos
Related Concept Videos
Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
Cancer
50.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
50.6K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K

